Case Study

Join us for a three-part peer to peer discussion on Alzheimer’s disease (AD) with our esteemed panel, exploring different facets of AD. The first part covers the various stages of the disease, the importance of early detection for effective intervention, clinical and biomarker changes in preclinical AD and how to determine if a patient with mild cognitive impairment is at high risk of developing AD. In the second part the experts discuss the accuracy of currently available diagnostic measures and the relevance of biomarkers. Finally, the panel members address identifying AD, and strategies to overcome them, along with cultural and social stigma related to dementia. They emphasize the importance of education among healthcare professionals, family members and even grandchildren about this disease.